News Home

Integral partnership gives TransRe three-pronged ILS strategy: CEO Sapnar

The arrangement grants the carrier access to different capital pools, the CEO said at the Insider London event on Tuesday.

RenRe falls to $77.1mn operating loss, raises $730mn in third-party funds

The additional $730mn in capital for its Upsilon RFO, DaVinci and Medici funds include $130mn of the company’s own money.

KCC pegs 2020 Atlantic hurricane season losses near $22bn

Last year’s season was “unprecedented” in terms of frequency, but not in terms of severity.

Rising reinsurance rates have had a knock-on impact on E&S property rates: RPS

Property insurance rates are rising by high single digits to 15% on clean accounts.

• Scor’s Kessler: Covid settlements require mix of relationships and arbitration
• Everest hit with $400mn Q4 reserve charge, $146mn in combined pandemic and cat losses
• Sierra quake bond prices 17% below January 2020 levels
• Up to $400bn of losses could drive five-year market hardening: Catlin
• B3i launches blockchain-based risk transfer platform Eurapco Unity
• Heritage estimates Q4 weather losses, separation costs at $46mn

Opinion

Swiss Re's fund launch is a bigger ILS pivot than it may seem

Aon's new cat facility points to ILS ambitions from backers

Lloyd's & ILS: Perfect match on paper, but early years stormy

Swapping out agg risk for tail risk

Analysis

ILS trends to watch in 2021

The sector has received a post-Covid boost heading into January, with strong interest in liquid cat bonds, but challenges around structures, pandemic exposures and lifting ESG commitments will remain.

ILS sector claws back pandemic outflow as specialist AuM recovers to $72bn

Specialist AuM rose 3% over the half year to 1 January, with Leadenhall, Fermat and Hudson Structured the biggest gainers.

Cat bond brokers bullish that post-Covid demand surge will drive new peak

Slew of maturities and competitive pricing environment make the cat bond market attractive for sponsors, brokers say

Cat bond volumes rise to new high in 2020

There were nearly twice as many new issuances than in 2019, but margins have remained elevated in the post-pandemic rebound.

Supplements

(Re)Connect 2020 - ILS Roundtable

Covid-19 may have been the biggest talking point in the (re)insurance markets this year but arguably, the pandemic is being overtaken by several other factors – ILS market dynamics amongst them.

Investor Guide to ILS: H2 2020

Covid-19 and ILS strategies: locking down diversification benefits.